HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 274140Generated: October 25, 2026
Azobisisobutyronitrile → 2-butyl-3-[3-bromo-2-(2-ethoxycarbonylphenyl)-2H-indazol-5-yl]methyl-3H-imidazo[4,5-b]pyridine
https://huagongshe.com/reaction/274140
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Azobisisobutyronitrile | HCID 6547 | — |
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | N-bromobutanimide | HCID 67184 | — |
| Reactant | 2-butyl-1H-imidazo[4,5-b]pyridine | HCID 12467710 | — |
| Reactant | ethyl 2-(3-bromo-5-methyl-2H-indazol-2-yl)benzoate | HCID 20094549 | — |
| Solvent | Carbon Tetrachloride | HCID 5943 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | 2-butyl-3-[3-bromo-2-(2-ethoxycarbonylphenyl)-2H-indazol-5-yl]methyl-3H-imidazo[4,5-b]pyridine | HCID 20094521 | 40.5% |
Reaction Steps
Carbon tetrachloride (4 ml) was added to ethyl 2-(3-bromo-5-methyl-2H-indazol-2-yl)benzoate (0.300 g, 0.835 mmol) as obtained in Reference Example 4, and the mixture was stirred. Thereto were added N-bromosuccinimide (0.149 g, 0.835 mmol) and azobisisobutyronitrile (14 mg, 0.0835 mmol), and the mixture was refluxed under heating for 3.5 hours. After cooling, the mixture was filtered, and the cake was washed with carbon tetrachloride (1 ml) and the filtrate was concentrated. The residue was then dissolved in DMF (dimethylformamide, 1 ml) and added to a solution obtained by adding sodium hydride (27 mg, 0.668 mmol) to 2-butyl-1H-imidazo[4,5-b]pyridine (0.117 g, 0.668 mmol) in DMF (2 ml) and stirring the solution for 30 minutes. The mixture was stirred at room temperature for 30 minutes, concentrated, and partitioned by ethyl acetate (5 ml) and water (5 ml). The organic layer was washed twice with water (5 ml), dried over magnesium sulfate, and then filtered. The filtrate was concentrated and subjected to flash chromatography on silica gel using a mixed solvent of hexane/ethyl acetate (1:2), whereby 0.144 g of 2-butyl-3-[3-bromo-2-(2-ethoxycarbonylphenyl)-2H-indazol-5-yl]methyl-3H-imidazo[4,5-b]pyridine was obtained.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05387684 |
|---|
| Source dataset | uspto-grants-1995_02 |
|---|
| ORD ID | ord-6166542bfa0a4a0aa5e65c42e0dfb78e |
|---|
| Source note | uspto-grants-1995_02 |
|---|